Servier Uk

Servier Uk company information, Employees & Contact Information

Explore related pages

Related company profiles:

Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a meaningful social impact for patients and contributing to a sustainable world. The Group’s unique governance model ensures its independence while fostering long-term innovation, with 100% of its profits reinvested in the company’s development. As a world leader in cardiometabolism and venous diseases, Servier drives transformative innovation in chronic conditions through a holistic approach, making patient adherence a priority across the globe. Its ambition is to become a leading player in rare cancers, which is why the Group invests heavily in oncology, allocating close to 70% of its R&D budget to this field. By leveraging precision medicine, Servier develops therapies that are targeted and effective. Bolstered by its success in oncology, Servier has expanded into neurology, a key driver of future growth. The Group focuses on a select number of neurodegenerative diseases, where accurate patient profiling enables targeted therapeutic responses through precision medicine. To further enhance access to high-quality, affordable care, Servier also provides an extensive range of generic medicines. In all its activities and at every stage of the medicine life cycle, the Group integrates the patient’s voice. Headquartered in France, Servier operates in close to 140 countries. In 2023-2024, the Group, which employs over 22,000 people worldwide, achieved sales revenue of €5.9 billion. To report a side effect with one of our products, please visit https://www.servier.co.uk/report-a-side-effect/ Reporting forms and information can also be found at www.mhra.gov.uk/yellowcard M-NO-UK-02396 Date of Prep : April 2025

Company Details

Employees
42
Address
Sefton House, Sefton Park, Bells Hill, Stoke Poges,buckinghamshire Sl2 4js,united Kingdom
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Stoke Poges, Buckinghamshire
Looking for a particular Servier Uk employee's phone or email?

Servier Uk Questions

News

Biogaran sale talks renew fears over foreign control of French pharma - RFI

Biogaran sale talks renew fears over foreign control of French pharma RFI

Servier Buys Fragile X Syndrome Candidate for up to $450M - Genetic Engineering and Biotechnology News

Servier Buys Fragile X Syndrome Candidate for up to $450M Genetic Engineering and Biotechnology News

Servier acquires Kaerus Bioscience’s FXS candidate for US$450m - European Biotechnology Magazine

Servier acquires Kaerus Bioscience’s FXS candidate for US$450m European Biotechnology Magazine

See our bases throughout the world - Servier

See our bases throughout the world Servier

NHS lawsuit against Servier Laboratories reaches Supreme Court - Generics and Biosimilars Initiative

NHS lawsuit against Servier Laboratories reaches Supreme Court Generics and Biosimilars Initiative

The Servier Case: The Game isn’t Over Yet - Dechert

The Servier Case: The Game isn’t Over Yet Dechert

U.K. Supreme Court rejects NHS claim of €220M financial loss in Servier patent lawsuit - Fierce Pharma

U.K. Supreme Court rejects NHS claim of €220M financial loss in Servier patent lawsuit Fierce Pharma

Drugmaker Servier loses EU court fight over pay-for-delay deals - Reuters

Drugmaker Servier loses EU court fight over pay-for-delay deals Reuters

Soldier sold £75k of equipment ‘attractive to terrorists’ on eBay - The Telegraph

Soldier sold £75k of equipment ‘attractive to terrorists’ on eBay The Telegraph

Victory Road: NHS successful in 11 year claim against Servier - PharmaTimes

Victory Road: NHS successful in 11 year claim against Servier PharmaTimes

Servier acquires treatment for autism genetic cause Fragile X syndrome - European Pharmaceutical Review

Servier acquires treatment for autism genetic cause Fragile X syndrome European Pharmaceutical Review

The One that Almost Got Away – The CJEU’s Judgments in Servier - Wolters Kluwer

The One that Almost Got Away – The CJEU’s Judgments in Servier Wolters Kluwer

Learn more about our development portfolio - Servier

Learn more about our development portfolio Servier

Servier supercharges neuro pipeline with $450M deal for Fragile X syndrome candidate - Fierce Biotech

Servier supercharges neuro pipeline with $450M deal for Fragile X syndrome candidate Fierce Biotech

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder - BioSpace

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder BioSpace

UK Supreme Court rules in favour of Servier in NHS patent lawsuit - PMLiVE

UK Supreme Court rules in favour of Servier in NHS patent lawsuit PMLiVE

Baker McKenzie Steers Servier On $450M Autism Drug Buy - Law360

Baker McKenzie Steers Servier On $450M Autism Drug Buy Law360

Servier acquires Kaerus’ Fragile X syndrome candidate for up to $450m - World Pharmaceutical Frontiers

Servier acquires Kaerus’ Fragile X syndrome candidate for up to $450m World Pharmaceutical Frontiers

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M - Fierce Pharma

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M Fierce Pharma

Our commitment to oncology - Servier

Our commitment to oncology Servier

French pharma firm found guilty over medical scandal in which up to 2,000 died - The Guardian

French pharma firm found guilty over medical scandal in which up to 2,000 died The Guardian

Servier unveils its 2030 ambition and reveals a new visual identity - PR Newswire UK

Servier unveils its 2030 ambition and reveals a new visual identity PR Newswire UK

EU Court of Justice Takes a Firm Stance Against Patent Settlement Agreements - Skadden, Arps, Slate, Meagher & Flom LLP

EU Court of Justice Takes a Firm Stance Against Patent Settlement Agreements Skadden, Arps, Slate, Meagher & Flom LLP

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma - The New England Journal of Medicine

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma The New England Journal of Medicine

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Pharma 50: The top pharma companies in the world for 2025 drugdiscoverytrends.com

Servier v. Commission (Case T 691/14): 5 crucial points of the second “pay-for-delay” decision of the EU General Court - Wolters Kluwer

Servier v. Commission (Case T 691/14): 5 crucial points of the second “pay-for-delay” decision of the EU General Court Wolters Kluwer

Servier and MiNA Partner to Create Entirely New Class of Drugs - BioSpace

Servier and MiNA Partner to Create Entirely New Class of Drugs BioSpace

Health authorities should have pushed alternative medication, Servier tells UK court - Global Competition Review

Health authorities should have pushed alternative medication, Servier tells UK court Global Competition Review

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles - Reuters

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles Reuters

Servier UK appoints new chief executive - Pharmafile

Servier UK appoints new chief executive Pharmafile

Former Ruffer director Harry Sevier launches Lulworth Investment Management - Investment Week

Former Ruffer director Harry Sevier launches Lulworth Investment Management Investment Week

Servier completes the acquisition of MVA-member company Symphogen - mva.org

Servier completes the acquisition of MVA-member company Symphogen mva.org

MVA member company 2N Pharma won the Servier Golden Ticket! - mva.org

MVA member company 2N Pharma won the Servier Golden Ticket! mva.org

Servier and UCL collaborate in fight against immune-inflammatory diseases | Innovation & Enterprise - UCL - University College London

Servier and UCL collaborate in fight against immune-inflammatory diseases | Innovation & Enterprise - UCL University College London

Case summary: Secretary of State for Health v Servier Laboratories Limited - Simmons & Simmons

Case summary: Secretary of State for Health v Servier Laboratories Limited Simmons & Simmons

France shaken by fresh scandal over weight-loss drug linked to deaths - The Guardian

France shaken by fresh scandal over weight-loss drug linked to deaths The Guardian

France braced for diabetic drug scandal report - BBC

France braced for diabetic drug scandal report BBC

Man accused of stealing £117k of Army kit from Larkhill will face trial - Salisbury Journal

Man accused of stealing £117k of Army kit from Larkhill will face trial Salisbury Journal

Servier ‘pay for delay’ litigation: Monckton success for NHS in the Court of Appeal - Monckton Chambers

Servier ‘pay for delay’ litigation: Monckton success for NHS in the Court of Appeal Monckton Chambers

French patients sue over weight-loss drug linked to deaths - The Guardian

French patients sue over weight-loss drug linked to deaths The Guardian

Court of Justice of the EU upholds EU Commission Decisions in Servier “Pay for Delay” appeals - Monckton Chambers

Court of Justice of the EU upholds EU Commission Decisions in Servier “Pay for Delay” appeals Monckton Chambers

Servier and UCL: pursuing breakthroughs in immune-inflammatory disease - University College London

Servier and UCL: pursuing breakthroughs in immune-inflammatory disease University College London

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant - IAM Patent

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant IAM Patent

Servier's Vorasidenib Receives Approval as Clinical Urgently Needed Drug to be Used in Boao Lecheng Pilot Zone - The Malaysian Reserve

Servier's Vorasidenib Receives Approval as Clinical Urgently Needed Drug to be Used in Boao Lecheng Pilot Zone The Malaysian Reserve

Swimmer Archie Goodburn who has incurable brain cancer is given 'hope' - Daily Mail

Swimmer Archie Goodburn who has incurable brain cancer is given 'hope' Daily Mail

Mediator drug: French pharmaceutical firm fined over weight loss pill - BBC

Mediator drug: French pharmaceutical firm fined over weight loss pill BBC

Daniel Piccinin KC - Brick Court Chambers

Daniel Piccinin KC Brick Court Chambers

Man accused of stealing £117k of Army kit from Larkhill will face trial - Wiltshire Times

Man accused of stealing £117k of Army kit from Larkhill will face trial Wiltshire Times

Tort: Causing loss by unlawful means - The Law Society Gazette

Tort: Causing loss by unlawful means The Law Society Gazette

Top Servier Uk Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant